ArticleAlimentary pharmacology & therapeutics2025

Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study.

Ronen Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.